Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TICAGRELOR | 90MG | TABLET | Resolved | 2024-10-24 | 2025-01-10 | 241081 |
| APO-TICAGRELOR | 90MG | TABLET | Resolved | 2023-06-16 | 2023-08-23 | 195049 |
| APO-TICAGRELOR | 90MG | TABLET | Resolved | 2023-10-06 | 2023-12-08 | 206569 |
| APO-TICAGRELOR | 90MG | TABLET | Resolved | 2023-12-22 | 2024-04-05 | 214250 |
| APO-TICAGRELOR | 90MG | TABLET | Resolved | 2024-01-19 | 2024-03-29 | 216675 |
| APO-TICAGRELOR | 90MG | TABLET | Resolved | 2024-04-12 | 2024-07-05 | 225026 |
| APO-TIMOP | 0.5% | SOLUTION | Resolved | 2024-01-05 | 2024-06-28 | 215215 |
| APO-TIMOP | 0.5% | SOLUTION | Actual shortage | 2025-01-16 | 2025-03-20 | 247865 |
| APO-TIMOP | 0.5% | SOLUTION | Resolved | 2018-05-08 | 2019-02-05 | 48866 |
| APO-TIMOP | 0.5% | SOLUTION | Resolved | 2018-05-15 | 2018-11-02 | 49509 |
| APO-TIMOP | 0.5% | SOLUTION | Resolved | 2019-09-04 | 2020-07-29 | 92992 |
| APO-TIMOP | 0.5% | SOLUTION | Resolved | 2021-01-04 | 2021-12-13 | 130810 |
| APO-TIMOP GEL | 0.5% | SOLUTION | Resolved | 2017-03-11 | 2019-02-05 | 510 |
| APO-TIMOP | 0.25% | LIQUID | Resolved | 2017-03-11 | 2019-01-03 | 513 |
| APO-TIZANIDINE | 4MG | TABLET | Actual shortage | 2025-04-17 | 2025-05-08 | 255208 |
| APO-TOBRAMYCIN | 0.3% | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19123 |
| APO-TOLTERODINE | 1MG | TABLET | Resolved | 2017-03-11 | 2017-11-08 | 516 |
| APO-TOLTERODINE | 2MG | TABLET | Resolved | 2017-03-11 | 2017-11-07 | 519 |
| APO-TOLTERODINE | 2MG | TABLET | Resolved | 2017-03-11 | 2018-02-28 | 523 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-03-21 | 2017-03-21 | 3746 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-FLUVOXAMINE | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |